Fierce Health Payers June 23, 2021
Sempre Health has locked up another $15 million in financing as it looks to expand the company’s program to trim costs for behavioral health medication and cut skyrocketing healthcare system losses when patients skip their medications.
The series B funding was led by the Blue Venture Fund—a collaboration of Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association and Sandbox, to which 35 BCBS companies have committed more than $890 million across four funds.
UPMC Enterprises and existing investors Rethink Impact, LifeForce Capital and Industry Ventures also participated.
Sempre Health plans to use the fresh capital to advance its two-sided network of payers and pharma manufacturers nationwide and to increase the number of chronic disease patients Sempre can...